These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37986225)

  • 1. Epigenetic regulation of asymmetric cell division by the LIBR-BRD4 axis.
    Chen HF; Chang CT; Hsu KW; Peng PH; Lai JC; Hung MC; Wu KJ
    Nucleic Acids Res; 2024 Jan; 52(1):154-165. PubMed ID: 37986225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
    Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of bromodomain protein 4 in regulation of stem cell identity.
    Dey A; Uppal S; Giri J; Misra HS
    Stem Cells; 2021 Dec; 39(12):1615-1624. PubMed ID: 34520583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A deregulated m
    Lu X; Peng L; Ding J; Li Y; Li Q; Rao M; Shu T; He X; Liu C; Ye J; Liu W; You H
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2304534120. PubMed ID: 37782793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRD4-binding enhancer promotes CRC progression by interacting with YY1 to activate the Wnt pathway through upregulation of TCF7L2.
    Duan B; Zhou X; Zhang X; Qiu F; Zhang S; Chen Y; Yang J; Wang J; Tan W
    Biochem Pharmacol; 2023 Dec; 218():115877. PubMed ID: 37879498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA
    Pistoni M; Rossi T; Donati B; Torricelli F; Polano M; Ciarrocchi A
    Mol Cancer Res; 2021 May; 19(5):799-811. PubMed ID: 33547232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA MALAT1 Promotes Laryngocarcinoma Development by Targeting miR-708-5p/BRD4 Axis to Regulate YAP1-Mediated Epithelial-Mesenchymal Transition.
    Wu X; Tan Y; Tang X
    Biomed Res Int; 2022; 2022():8093949. PubMed ID: 35601153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
    Chen Y; Ying Y; Ma W; Ma H; Shi L; Gao X; Jia M; Li M; Song X; Kong W; Chen W; Zheng X; Muluh TA; Wang X; Wang M; Shu XS
    Cancer Res; 2024 Apr; 84(8):1237-1251. PubMed ID: 38241700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma.
    Markman RL; Webber LP; Nascimento Filho CHV; Reis LA; Vargas PA; Lopes MA; Zanella V; Martins MD; Squarize CH; Castilho RM
    Cell Oncol (Dordr); 2019 Apr; 42(2):143-155. PubMed ID: 30539410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct layers of BRD4-PTEFb reveal bromodomain-independent function in transcriptional regulation.
    Zheng B; Gold S; Iwanaszko M; Howard BC; Wang L; Shilatifard A
    Mol Cell; 2023 Aug; 83(16):2896-2910.e4. PubMed ID: 37442129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRD4 in physiology and pathology: ''BET'' on its partners.
    Liang Y; Tian J; Wu T
    Bioessays; 2021 Dec; 43(12):e2100180. PubMed ID: 34697817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1.
    Li N; Zhang E; Li Z; Lv S; Zhao X; Ke Q; Zou Q; Li W; Wang Y; Guo H; Song T; Sun L
    J Biol Chem; 2024 Mar; 300(3):105707. PubMed ID: 38309505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological stage-associated non-coding RNA long intergenic non-protein coding RNA 1234 (LINC01234) participation in cell cycle regulation in adrenocortical carcinoma through bromodomain-containing protein 4 (BRD4) expression mediation via sponging microRNA (miR)-140-3p.
    Zhu DD; Yu XB; Jiang W; Zhu Y
    Bioengineered; 2022 May; 13(5):13607-13621. PubMed ID: 35765893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging roles of and therapeutic strategies targeting BRD4 in cancer.
    White ME; Fenger JM; Carson WE
    Cell Immunol; 2019 Mar; 337():48-53. PubMed ID: 30832981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRD4 Promotes Gastric Cancer Progression and Metastasis through Acetylation-Dependent Stabilization of Snail.
    Qin ZY; Wang T; Su S; Shen LT; Zhu GX; Liu Q; Zhang L; Liu KW; Zhang Y; Zhou ZH; Zhang XN; Wen LZ; Yao YL; Sun WJ; Guo Y; Liu KJ; Liu L; Wang XW; Wei YL; Wang J; Xiao HL; Liu P; Bian XW; Chen DF; Wang B
    Cancer Res; 2019 Oct; 79(19):4869-4881. PubMed ID: 31311807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach.
    Shanmugam V; Muthukrishnan S
    J Biomol Struct Dyn; 2023; 41(23):14524-14539. PubMed ID: 36841551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review).
    Yongprayoon V; Wattanakul N; Khomate W; Apithanangsiri N; Kasitipradit T; Nantajit D; Tavassoli M
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38606512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAM222A, Part of the BET-Regulated Basal Endothelial Transcriptome, Is a Novel Determinant of Endothelial Biology and Angiogenesis-Brief Report.
    Tzani A; Haemmig S; Cheng HS; Pérez-Cremades D; Heuschkel MA; Jamaiyar A; Singh SA; Aikawa M; Yu PB; Wang T; Sun Y; Feinberg MW; Plutzky J
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):143-155. PubMed ID: 37942611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells.
    Gonzales-Cope M; Sidoli S; Bhanu NV; Won KJ; Garcia BA
    BMC Genomics; 2016 Feb; 17():95. PubMed ID: 26847871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer.
    Rodriguez RM; Huidobro C; Urdinguio RG; Mangas C; Soldevilla B; Domínguez G; Bonilla F; Fernandez AF; Fraga MF
    J Mol Med (Berl); 2012 May; 90(5):587-95. PubMed ID: 22120039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.